As Chair of the 2017 ISPE Process Validation Conference, I am pleased to invite you to join us in Bethesda, Maryland, 12 – 14 September to expand your knowledge of the lifecycle approach to process validation.
In addition to case studies and lessons learned that will be presented by your colleagues, the conference offers multiple benchmarking opportunities and interactive exercises to experience application of the practices discussed.
This event will provide you with insight into implementation strategies to meet new expectations and significant changes in the PV lifecycle approach. You’ll find solutions to your most pressing challenges in the various forums with regulatory leaders and industry experts.This year’s conference will cover all stages in the PV lifecycle approach, and delve into areas that present more significant challenges and opportunities, including:
Keynote speakers include:
Additionally, you can sharpen your process validation statistics knowledge by taking advantage of the 2017 ISPE Process Validation Statistics Conference, which takes place right after the Process Validation Conference. Attendees of both conferences will have access to a networking reception and two concurrent evening sessions on 13 September. Save an additional 25% by registering for both conferences.
For more information and to register, please visit www.ISPE.org/2017-Process-Validation-Conference.
We look forward to seeing you in September!
Best Regards
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...